CTLA4 and meningioma: The use of ipilimumab (NCT03604976) targeting CTLA-4, and nivolumab (NCT03604978) targeting PD-1, as well as, both medications together (NCT02648997) in conjunction with stereotactic radiosurgery in recurrent atypical and anaplastic meningiomas is currently being investigated.